Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen ExoRNeasy Midi and Maxi Kits; NGS Panel/Bioinformatics Bundles

Qiagen is launching its exoRNeasy Midi and Maxi Kits for isolation of exosomes and other extracellular vesicles from urine and other samples, as well as the miRNeasy 96 Advanced QiaCube HT Kit for automated purification of total RNA, including miRNA, from serum and plasma samples.

The exoRNeasy Midi and Maxi Kits use membrane affinity technology for RNA isolation from exosomes and other extracellular vesicles, and can provide results in about an hour, the company said. The Midi column enables processing of smaller sample volumes (1 ml serum/plasma and 4 ml or less of urine), while the Maxi format allows the use of large sample volumes (up to 4 ml serum/plasma, 16 ml of urine, and 32 ml of cell culture supernatant).

The miRNeasy 96 Advanced QiaCube HT Kit is designed for automated high-throughput purification of cell-free total RNA, primarily miRNA and other small RNA, from small volumes of serum and plasma on the QiaCube HT instrument. The phenol-free protocol uses easy-to-automate spin column technology in a 96-well format and minimizes hands-on time to remove contaminants and inhibitors, the company noted.

The company also said it is launching new bundles of its bioinformatics solutions with preconfigured QiaSeq DNA panels and custom panels for use on any sequencing platform, as well as with QiaAct targeted gene and custom panels for use on the Qiagen GeneReader NGS System. The new assay-and-software bundles include Qiagen's CLC Genomics Workbench and Clinical Insight-Interpret (QCI-I) for QiaSeq DNA panels and QCI-I for QiaAct panels.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.